Facebook
Twitter
Telegram
Fehler meldenUnited Therapeutics Corporation Bargeldumlauf 2011-2024 | UTHR
Bargeldumlauf Jährlich United Therapeutics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operativer Cashflow |
978 M | 802 M | 598 M | 756 M | -207 M | 778 M | 474 M | 644 M | 383 M | - | - | 324 M | 250 M |
Abschreibung & Amortisation |
53.2 M | 51.3 M | 49.9 M | 49.9 M | 45.9 M | 35.9 M | 31 M | 31.6 M | 32.9 M | 32.2 M | 31.3 M | 27.1 M | 20.5 M |
Kreditorenbuchhaltung |
5.6 M | 4.1 M | 3.8 M | 4.1 M | 9.9 M | 23.1 M | 8.4 M | 8.1 M | 7.5 M | 7 M | 6.71 M | 10.2 M | 47.3 M |
Accounts Erhaltbar |
279 M | 220 M | 199 M | 157 M | 151 M | 176 M | 297 M | 214 M | 193 M | 162 M | 126 M | 117 M | 88.7 M |
Allgemeine Reserven |
112 M | 102 M | 93.8 M | 86.5 M | 93.4 M | 101 M | 108 M | 100 M | 81.3 M | 66.9 M | 47.8 M | 37.3 M | 46 M |
Alle Zahlen in USD-Währung
Bargeldumlauf Vierteljährlich United Therapeutics Corporation
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operativer Cashflow |
376 M | - | - | - | 375 M | - | 674 M | - | 289 M | - | 424 M | - | 89.8 M | - | 630 M | 379 M | 215 M | - | -309 M | -494 M | -627 M | - | 693 M | 456 M | 276 M | - | 560 M | 302 M | 231 M | - | 480 M | 252 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 37.6 M | - | 199 M | 118 M | 53.4 M |
Abschreibung & Amortisation |
15 M | - | - | - | 13.3 M | - | 38.1 M | - | 12.5 M | - | 37.3 M | - | 12.5 M | - | 36.8 M | 25 M | 12.4 M | - | 33.4 M | 20.7 M | 10.3 M | - | 25.4 M | 16 M | 7.9 M | - | 23.3 M | 15.6 M | 7.9 M | - | 23.8 M | 15.6 M | 7.7 M | - | 25 M | 16.7 M | 8.3 M | - | 23.3 M | 15.2 M | 7.56 M | - | 23.5 M | 15.8 M | 8.16 M | - | 19.9 M | 12.9 M | 6.65 M | - | 15.6 M | 10.6 M | 5.81 M |
Kreditorenbuchhaltung |
- | - | - | - | - | - | - | - | - | 3.8 M | - | - | - | 4.1 M | - | - | - | 9.9 M | - | - | - | 23.1 M | - | - | - | 8.4 M | - | - | - | 8.1 M | - | - | - | 7.5 M | - | - | - | 7 M | - | - | - | 6.71 M | - | 9.38 M | 10.2 M | 10.2 M | 10.1 M | 10.2 M | 10.2 M | 47.3 M | 47.3 M | 47.3 M | 47.3 M |
Accounts Erhaltbar |
307 M | 279 M | 259 M | 273 M | 134 M | 220 M | 232 M | - | 170 M | 199 M | 213 M | 173 M | 141 M | 157 M | 157 M | 157 M | 157 M | 151 M | 151 M | 151 M | 151 M | 176 M | 176 M | 176 M | 176 M | 297 M | 297 M | 297 M | 297 M | 214 M | 214 M | 214 M | 214 M | 193 M | 193 M | 193 M | 193 M | 162 M | 162 M | 162 M | 162 M | 126 M | 126 M | 126 M | 126 M | 117 M | 117 M | 117 M | 117 M | 88.7 M | 88.7 M | 88.7 M | 88.7 M |
Allgemeine Reserven |
120 M | 112 M | 104 M | 103 M | 102 M | 102 M | 91 M | - | 88.2 M | 93.8 M | 96.7 M | 89.9 M | 92.2 M | 86.5 M | 86.5 M | 86.5 M | 86.5 M | 93.4 M | 93.4 M | 93.4 M | 93.4 M | 101 M | 101 M | 101 M | 101 M | 108 M | 108 M | 108 M | 108 M | 100 M | 100 M | 100 M | 100 M | 81.3 M | 81.3 M | 81.3 M | 81.3 M | 66.9 M | 66.9 M | 66.9 M | 66.9 M | 47.8 M | 47.8 M | 47.8 M | 47.8 M | 37.3 M | 37.3 M | 37.3 M | 37.3 M | 46 M | 46 M | 46 M | 46 M |
Alle Zahlen in USD-Währung